CION Ameerpet
Screening Guide · Reviewed by CION Oncologists · NABH Accredited
Had the HPV Vaccine? You Still Need Cervical Screening
If you have been vaccinated against HPV, you have already done the single most effective thing available to lower your risk of cervical cancer. What you have not done is remove the need for screening. The vaccine and the screening test do two entirely different jobs — one stops most high-risk HPV infections from ever taking hold, the other finds the cell changes caused by the infections it does not cover. Guidance from the WHO, and the screening frameworks in use across India, apply the same schedule to vaccinated and unvaccinated women alike. This page explains why that is, what the vaccine genuinely covers, and how to arrange a test at CION's 7 NABH-accredited Hyderabad locations.
- Two different jobs — the vaccine prevents infection, screening finds change that has already started
- HPV 16 and 18 cause around 70% of cervical cancers — the rest come from types the vaccine does not fully cover
- The vaccine cannot clear an old infection — it protects against what you have not met yet
- 45-minute consultation — with a woman doctor available on request, at every CION location
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The Short Answer: Yes — Screening Still Applies to You
Vaccination and screening are not two versions of the same protection. The vaccine works before infection; screening works after it. A vaccinated woman who meets a high-risk HPV type her vaccine does not cover can still develop the slow cell changes that lead to cervical cancer, and nothing about having been vaccinated makes those changes visible or symptomatic. The only way to find them is to look for them.
That is why the WHO's 2021 cervical screening guideline sets out its recommendations for women in the general population regardless of HPV vaccination status, and why India's national cancer screening framework does the same. No major guideline anywhere currently tells a vaccinated woman to skip screening altogether. Some countries are studying longer intervals for cohorts vaccinated in childhood, but that is a question about frequency, not about whether screening happens at all.
There is a second reason, and in India it matters more than the first. Vaccination programmes reach most women some years after the age at which the vaccine works best. If you were vaccinated in your twenties or thirties — as most Indian women who have been vaccinated at all were — there is a reasonable chance you had already met one or more HPV types before the first dose. The vaccine did nothing about those, because it was never designed to. To understand what the vaccine actually does and when it works best, read our guide to the HPV vaccine and how it protects against cervical cancer; for the wider picture of how the disease develops, start with the cervical cancer overview.
Did You Know? The WHO's global strategy for eliminating cervical cancer is built on three targets, not one: 90% of girls fully vaccinated by age 15, 70% of women screened with a high-performance test by 35 and again by 45, and 90% of women with cervical disease treated. Screening was never the fallback for women who missed the vaccine — it is one of the three pillars, and it applies to vaccinated women too. Source: WHO Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem (2020).
What the Vaccine Covers — and What It Cannot
The vaccine is genuinely excellent at the job it was built for. Understanding the edges of that job is what tells you why the screening test is still on your calendar.
What it covers
The Two Types Behind Most Cancers
HPV 16 and 18 together account for roughly 70% of cervical cancers worldwide. Protection against persistent infection with these two types is the vaccine's central achievement, and it is very high when the course is given before any exposure.
What it covers
Several Further High-Risk Types
The broader-coverage formulations extend protection to five additional oncogenic types, plus the two low-risk types responsible for most genital warts. Which formulation you received changes how much of the residual risk is covered.
The gap
Every Other High-Risk Type
More than a dozen HPV types are classified as oncogenic. No vaccine covers all of them. An infection with an uncovered type behaves exactly like any other — silently, over years — and only a test will find it. See which HPV types are high-risk.
The gap
Infections You Already Had
The vaccine is preventive, not therapeutic. It stops your immune system meeting a covered type for the first time; it cannot clear a virus already established in the cervix. What an HPV-positive result means.
The gap
An Incomplete Course
Protection depends on completing the schedule appropriate to your age at the first dose. A course started and abandoned does not deliver the protection quoted in trials. How many doses you need.
The gap
The Rare Non-HPV Cancers
A small minority of cervical cancers — certain uncommon glandular subtypes in particular — are not driven by HPV at all. No HPV vaccine can prevent these, and screening remains the only route to finding them early.
None of this makes the vaccine less worth having. It simply means the vaccine reduces your risk substantially rather than to zero — and residual risk is exactly what a screening programme is designed to catch.
Three Situations Where Post-Vaccination Screening Matters Most
For most vaccinated women the message is simply “carry on with the normal schedule”. In these three situations, the schedule deserves particular attention.
1. You were vaccinated as an adult
The vaccine performs best when it is given before any sexual contact, which is why programmes target girls aged 9 to 14. Vaccination later in life is still worthwhile, but the chance that some HPV exposure has already occurred rises with every year of delay — and that exposure is invisible without a test. If you were vaccinated in adulthood, treat screening as the primary safeguard and the vaccine as the addition, not the reverse. See what age the HPV vaccine works best at.
2. You have a symptom, at any time
Screening is for women who feel well. A symptom is assessed on its own merit and does not wait for the next scheduled test — and being vaccinated is not a reason to reinterpret it. Bleeding after sex, bleeding after the menopause, bleeding between periods or a persistent change in discharge should be examined whether or not you have had the vaccine. Start with our guide to abnormal vaginal bleeding.
3. Your immune system is suppressed
Women living with HIV, transplant recipients and women on long-term immunosuppressive treatment clear HPV infections less reliably, so infections persist and progress more often. Guidance for this group starts screening earlier and repeats it more frequently, and vaccination does not remove that requirement. Read cervical screening if you have HIV or low immunity.
The reassuring part: a vaccinated woman who screens on schedule has two independent layers of protection — one that stops most infections happening, and one that catches what does happen while it is still precancerous and treatable in a single outpatient visit. Cervical cancer typically takes 10 to 15 years to develop from a persistent infection, which is an unusually generous window. Not using it is the only real mistake.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Vaccinated Is a Great Start. Screened Is the Finish.
A screening appointment takes about fifteen minutes. A woman doctor is available on request at every CION location, with same-week slots across Hyderabad.
What Cervical Screening Actually Involves
Women who were vaccinated as teenagers often reach their mid-twenties never having had a cervical examination, and the unfamiliarity is itself a reason for delay. Here is the whole appointment, start to finish.
Step 1 — A short history, including your vaccination record
Bring your vaccination card if you have it, or simply tell us roughly when you were vaccinated and how many doses you received. Age at first dose, number of doses and the interval since your last screening test are what determine which test we recommend today.
Step 2 — The sample itself
A speculum holds the vaginal walls apart so the cervix can be seen, and a soft brush sweeps cells from its surface. It takes under a minute and is usually described as briefly uncomfortable rather than painful. A female attendant is present throughout, and a woman doctor can be requested when you book.
Step 3 — Cytology, HPV testing, or both
The same sample can be examined for abnormal cells — the Pap smear — and tested for high-risk HPV DNA. The WHO now favours HPV DNA testing as the primary screening test because it is more sensitive for the changes that matter, and it is particularly informative for a vaccinated woman: a negative high-risk HPV result is strong evidence that nothing is developing. Our page on HPV test versus Pap smear sets out when each is used.
Step 4 — The result, and the next date
Most results are normal, and you leave with the date of your next test written down. If cells look abnormal or a high-risk type is detected, the next step is a colposcopy — the cervix examined under magnification in an outpatient clinic. That step usually finds precancerous change rather than cancer, and precancer is treatable in one visit. Where a cancer is confirmed, the case goes to CION's multidisciplinary tumour board before any plan is proposed, in line with NCCN and ESMO guidance, and treatment options are set out on our cervical cancer treatment in Hyderabad page.
Your Vaccination Status and What Screening Still Applies
A guide to the conversation, not a prescription. Your own schedule is set with a clinician who knows your age, your history and your last result.
| Your situation | What still applies | Why |
|---|---|---|
| Fully vaccinated before any sexual contact | The same screening schedule as an unvaccinated woman of your age | Excellent protection against the covered types; the uncovered oncogenic types remain |
| Vaccinated as an adult | The same schedule, and do not defer the first test | Exposure may have occurred before the first dose, and the vaccine cannot clear it |
| Partly vaccinated — course not completed | The same schedule; ask about completing the course | Protection quoted for the vaccine assumes the full age-appropriate schedule |
| Vaccinated, previous normal result | Continue at the interval your clinician set — usually every 3 to 5 years by test type | Interval is determined by which test was used, not by vaccination status |
| Vaccinated, HIV positive or immunosuppressed | Earlier start and a shorter interval than the general population | HPV infections persist and progress more readily when immunity is reduced |
| Vaccinated, but with a symptom now | An examination, not a screening test — and not a wait | Symptoms are investigated on their own merit at any point in the cycle of screening |
| Not vaccinated at all | Screening on schedule; vaccination is still worth discussing | Screening is the main protection for anyone the vaccine reached late or not at all |
Not sure how far apart your tests should be? Our guide to how often to get a Pap smear works through intervals by age and risk, and when to start and stop cervical screening covers the age boundaries.
Did You Know? HPV types 16 and 18 cause roughly 70% of cervical cancers worldwide. That single figure is the whole argument on this page: it is high enough to explain why vaccination transformed the outlook for cervical cancer, and short enough of 100% to explain why every national programme still screens vaccinated women. Sources: WHO cervical cancer fact sheet; IARC Monographs on human papillomaviruses.
Four Things Vaccinated Women Tell Us in Clinic
“I was told the vaccine prevents cervical cancer.”
It prevents the infections that cause most cervical cancer, which is not quite the same sentence. The gap between those two statements is small in percentage terms and large in consequence — and it is exactly the gap screening fills. Both statements can be true at once: the vaccine is the most important preventive step available, and screening is still required.
“My HPV test was negative, so I am finished.”
A negative high-risk HPV result is genuinely reassuring, and it is the reason a negative test buys a longer interval than a normal Pap alone. But it describes today, not the next decade. New exposure remains possible, which is why the result comes with a next date rather than a discharge. If you have tested positive at some point, whether HPV clears on its own explains what usually happens next.
“I have only ever had one partner.”
HPV is extraordinarily common, and a single lifetime partner is enough for transmission. Most sexually active adults encounter it at some point, and the great majority clear it without ever knowing. Screening is not a comment on anyone's history — it is a routine test for a very ordinary virus.
“I feel completely fine.”
Feeling fine is the expected state during the entire window when screening is useful. Precancerous change causes no symptoms at all, and early cervical cancer usually causes none either. That is precisely why the test exists for women who feel well, and why waiting for a symptom converts a treatable finding into a harder one.
Why Women in Hyderabad Screen With CION
A screening visit should be quick, private and clearly explained. That is the whole standard we hold ourselves to.
Woman doctor available on request
Pap and HPV test from one sample
45-minute detailed consultation
17 oncologists across the group
On-site colposcopy and biopsy
7 NABH-accredited Hyderabad locations
Transparent, itemised costs
EMI facility & insurance accepted
4.8 / 5 Google rating
Take The Next Step
You Did the Hard Part Already
Getting vaccinated took a decision. Getting screened takes fifteen minutes. Together they are as close to full protection as current medicine gets.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Screening After the HPV Vaccine — Frequently Asked Questions
I was vaccinated at 14. Do I really need a Pap smear in my twenties?
Yes. Being vaccinated early is the best possible starting position, because the vaccine works best before any exposure to HPV — but it covers the types responsible for around 70% of cervical cancers, not all of them. The remaining oncogenic types behave in exactly the same way and cause no symptoms while they do it. Every national screening programme, and the WHO guideline they draw on, currently recommends the same schedule for women who were vaccinated in childhood as for those who were not. Some countries are studying longer intervals for these cohorts, but that is a question about spacing, not about skipping screening.
Can the HPV vaccine clear an infection I already have?
No. The vaccine is preventive rather than therapeutic. It trains your immune system to recognise the covered HPV types before they arrive, so that a future exposure does not establish itself. It has no effect on a virus already present in the cervix and it does not treat existing cell changes. This is not a shortcoming — it is simply what the vaccine was designed to do. If you already know you are HPV positive, vaccination may still be worth discussing for the types you have not yet met, but the immediate priority is following the screening and follow-up plan your clinician has set.
My HPV test came back negative and I am vaccinated. Can I stop screening?
Not permanently. A negative high-risk HPV result is strong reassurance, and it is the reason HPV-based screening allows a longer gap between tests than cytology alone. What it tells you is that no high-risk type is detectable now. New exposure is still possible afterwards, so the result comes with a date for the next test rather than a discharge from the programme. Screening usually continues to the upper age limit used in your local guideline, at which point stopping is considered on the basis of your recent results and history rather than on vaccination status.
Which test is better for a vaccinated woman, the Pap smear or the HPV test?
For most women aged 30 and above the WHO now favours a high-risk HPV DNA test as the primary screening test, and that reasoning applies at least as strongly after vaccination. As vaccination reduces the number of abnormal cells a laboratory sees, the value of looking for the virus itself rises relative to looking for cell change. In practice both tests are often run from a single sample, which is called co-testing. At CION the choice is made from your age, your vaccination history and your previous results, and it is explained to you before anything is collected.
I only received one or two doses. Am I protected?
Partly, and the honest answer is that it depends on your age at the first dose. Schedules are set so that younger recipients need fewer doses than older ones to reach comparable protection, so a two-dose course started at 12 is not equivalent to a two-dose course started at 25. Bring whatever record you have to the consultation. We can advise on completing the course where that is appropriate, but in either case the screening recommendation does not change — an incomplete course is a reason to be more careful about screening, never less.
Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It is not a diagnosis and does not replace an individual screening plan. Screening intervals differ by age, test type, immune status and previous results — please confirm yours with a clinician rather than relying on any website.